Biotech

All Articles

Vaxcyte surges on 'stunning' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what analysts referred to as "remarkable" stage 1/2 records for its 31-valent pneu...

Recursion's mind condition test shows insufficient proof of efficiency

.Recursion has stumbled via a very early test of its own tech-enabled method to drug revelation, sta...

Acepodia, Pfizer click together for chemistry-based cell therapy

.Call it a situation of good chemical make up: Acepodia, a biotech based on Nobel Champion scientifi...

Praxis epilepsy medicine decreases seizures in stage 2 trial

.Praxis Accuracy Medicines has racked up yet another midphase win in epilepsy this year, along with ...

Three execs surrender as Dyne articles blended records for DMD prospect

.After getting away a medical grip a number of years back, Dyne Rehab has actually shown brand new s...

Arrowhead fires off period 3 records in rare metabolic health condition in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its hand ahead of a prospective showdown along with Ionis, ...

Pfizer, Valneva reveal lyme illness try efficient for second booster

.Pfizer and also Valneva might possess regarding pair of more years to wait just before they help ma...

Fierce Biotech Managing Editor Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Allow's dive into a conversation with Ayla Ellison, Ferocious Biotech Editor-in-Chief and also Mich...

New records show how Bayer's asundexian failed to prevent strokes

.Bayer put on hold the stage 3 trial for its element XIa prevention asundexian late last year after ...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its various sclerosis (MS) med tolebrutinib to the FDA, exec...